Buzz: Fosun Pharma readying for up to $600M IPO

China's Fosun Pharmaceutical, a growing drug manufacturing company, is poised to price an initial public offering in Hong Kong on Oct. 22 or Oct. 23, a source told Reuters. According to the company's website, Fosun was formed through the integration of Chongqing Yaoyou Pharmaceuticals and Jiangsu Wanbang Biopharmaceutical and has operations in drug manufacturing, research and marketing. Article

Suggested Articles

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

The FDA hit New Jersey-based CMO Tris Pharma with a warning letter, citing significant violations.

Celltrion remains optimistic it will get U.S. approval for its two biosimilar drugs, Rituxan and Herceptin, by the end of the year.